Obesidad abdominal, comorbilidad y metabólicamente sanos

Abstract

Abdominal obesity as a risk factor in itself is accompaniedby an increase in cardiovascular and metabolic comorbidity, such as high blood pressure, diabetes mellitus and dyslipidemia, despite this, there are patients with obesity who are metabolically healthy. A cross-sectional epidemiological investigation was carried out with 374 patients aged 20 yearsand over from office 7, in the town of La Hata, from January to June 2022, with the objective of determine in patients with abdominal obesity, comorbidity and the metabolically healthy. Family and individual medical records were used as a sourse of information. The results were put into tables in whole numbers and relative frequency for analysis. The main results were the prevalence of arterial hypertensionas a previous comorbidity and hypercholesterolemia and hypertriglyceridemia as hidden comorbidities. A third of the patients were metabolically healthy, witha predominance of womwnbetweenages of 50 and 59 years. It is concluded that abdominal obesity is associated with a high comorbidity due to non-communicable diseases in  addition to hidden comorbidity due to dyslipidemia in the study population, where a third of them were metabolically healthy.